Keywords: Biosumilars, CellTrion, Remsima, Johnson & Johnson, Remicade, Rheumatoid arthritis, Regulatory factors. GlobalData

World's first (official) biosimilar antibody goes to reumatoid arthritis

Article | 09 August 2012

Print This

The end of July 2012 proved exciting for the world of biosimilar manufacturers. However, for the regulatory officials worldwide it meant ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in